Investment Bank Drops Coverage of Helicos BioSciences

Leerink Swann dropped coverage of Helicos, citing both short-term and long-term challenges. It also called an acquisition of the firm unlikely.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.